Skip Navigation

Faculty Directory

David W. Dowdy, MD

  • Associate Professor

Departmental Affiliations

  • Epidemiology (Primary)
    • Division: Infectious Disease Epidemiology
  • International Health (Joint)
    • Division: Global Disease Epidemiology and Control
  • School of Medicine (Joint)

Center & Institute Affiliations

Contact Information

615 N. Wolfe Street
Room E6531
Baltimore, Maryland 21205

410-614-5022
410-614-0902

TB Modeling and Translational Epi Group

SciVal Research Profile

View Current Courses

Education

MD, Johns Hopkins School of Medicine, 2008
PhD, Johns Hopkins Bloomberg School of Public Health, 2008
ScM, Johns Hopkins Bloomberg School of Public Health, 2002
BS, Duke University, 1999

Overview

I am a junior investigator in the field of infectious disease epidemiology, and also a practicing general internist.  My interdisciplinary research lies at the nexus of infectious disease modeling, health economics, operational and implementation science, and classical epidemiology.  My primary interests are:

(1) Dynamic modeling and economic evaluation of TB and TB/HIV: My greatest research passion is evaluating the implementation and scale-up of TB and HIV control interventions, especially diagnostic and case-finding strategies.  I combine methods from traditional epidemiology, cost-effectiveness analysis, and epidemic modeling with the aim of answering questions of relevance to patients and policy-makers.  I serve on the steering committee of the Gates Foundation-funded TB-Modeling and Analysis Consortium (TB-MAC) and direct two NIH-funded projects related to modeling the scale-up of TB diagnostic tests.  I currently work with collaborators on projects based in Malawi, South Africa, Uganda, India, Zambia, Brazil, Canada, and the United States. 

(2) Translational epidemiology: I have great interest in creating modeling frameworks that allow decision-makers to translate epidemiological data into effective decisions.  I welcome collaboration from researchers, clinicians, or students having expertise in any field, who hope to create models to translate epidemiological data into meaningful policy, practical, or clinical decisions.

(3) Implementation science: I am interested not only in how interventions operate in idealized settings, but also improving how they are implemented in the real world.  Generally, implementation barriers are greater than theoretical scientific ones; I think it is critical to conduct research that will help us overcome them.

(4) Teaching and mentorship:  These are essential, and often-undervalued, skills in the field of epidemiology.  If our profession is to continue its record of success, I firmly believe that we need to train future leaders how to teach and mentor others, and also to do our best to serve as role models in that regard.

Honors and Awards

Awards since 2008:

2015 Excellence in Mentoring Award

2014 Golden Apple Teaching Award (large class)

2013 Advising, Mentoring, and Teaching Recognition Award (AMTRA), JHSPH

2012 B. Frank and Kathleen Polk Assistant Professor of Epidemiology

2012 Young Investigator Prize, International Union Against Tuberculosis and Lung Disease

2011  Tom Evans Teaching Award, Internal Medicine Residency Program, UCSF

2010  Diane Becker Award in Clinical Epidemiology and Prevention, Johns Hopkins GIM Housestaff Research Award

2010  Floyd Rector Clinical Science Research Award, Internal Medicine Residency Program, UCSF

2010  Teaching Excellence Award for Cherished Housestaff (TEACH), UCSF School of Medicine

2009  Julius Krevans Award for Outstanding Housestaff Service, San Francisco General Hospital

2008  Warfield T. Longcope Prize in Clinical Medicine, Johns Hopkins University School of Medicine

2008  David E. Rogers Award for Professionalism, Ethics, & Community, Johns Hopkins University School of Medicine

2008  Alpha Omega Alpha Honor Society

2008  Arthur M. Dannenberg, Jr. Award for Tuberculosis Research

  • infectious diseases
  • tuberculosis
  • HIV
  • epidemiology
  • mathematical modeling
  • implementation science
  • infectious disease dynamics
  • health economics

Publications from March-June 2016:

  • Bronner Murrison L, Ananthakrishnan R, Swaminathan A, Auguesteen S, Krishnan N, Pai M, Dowdy DW. How do patients access the private sector in Chennai, India? An evaluation of delays in tuberculosis diagnosis. Int J Tuberc Lung Dis. 2016 Apr;20(4):544-51.
  • Shrestha S, Chatterjee S, Rao KD, Dowdy DW. Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, India. J R Soc Interface. 2016 Mar;13(116).
  • Hanrahan CF, Haguma P, Ochom E, Kinera I, Cobelens F, Cattamanchi A, Davis L, Katamba A, Dowdy D. Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis. Open Forum Infect Dis. 2016 May 12;3(2):ofw068.
  • Bronner Murrison L, Ananthakrishnan R, Sukumar S, Augustine S, Krishnan N, Pai M, Dowdy DW. Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing. PLoS One. 2016 Jun 15;11(6):e0155775.
  • Jha S, Ismail N, Clark D, Lewis JJ, Omar S, Dreyer A, Chihota V, Churchyard G, Dowdy DW. Cost-Effectiveness of Automated Digital Microscopy for Diagnosis of Active Tuberculosis. PLoS One. 2016 Jun 20;11(6):e0157554.